Farlong Pharmaceutical   Report issue

For profit Phase 2
Founded: Walnut CA United States (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2016
NCT04069715
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

LongStar HealthPro, Inc. DBA Farlong Pharmaceutical